Skip to main content

Advertisement

SpringerLink
Log in

Glutathione S-transferase P1 gene polymorphism and bladder cancer susceptibility: an updated analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Studies investigating the association between glutathione S-transferase P1 (GSTP1) gene polymorphism and bladder cancer (BC) risk have reported conflicting results. In order to clarify the effect of GSTP1 polymorphism on the BC susceptibility, we conducted an updated system review of published epidemiology studies to provide more precise evidence. We performed a systematic search of PubMed, EMBASE, and China National Knowledge Infrastructure (CNKI). 20 studies with 4,428 BC cases and 5,457 controls were identified. The combined analyses based on all studies showed that there was a significant difference in the genotype distribution in GSTP1(A313G) polymorphism between BC cases and controls not only in Asians (GG vs. AA + AG, OR = 1.59, 95 % CI = 1.01–2.51) but also in Caucasians (GG vs. AA + AG, OR = 1.51, 95 % CI = 1.11–2.06). Upon stratification for smoking status, we observed no statistically significant difference in genotype distribution of GSTP1 in ever-smokers. Combination of the high-risk genotypes (GSTM1 null + GSTT1 null + GSTP1 313 A/G or G/G) demonstrated further increase in the BC risk (OR = 6.64, 95 %CI = 3.63–12.16). This meta-analysis suggests that GSTP1 313 G/G polymorphism is a strong predisposing risk factor for BC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Chang CH, Chang CL, Tsai CW et al (2009) Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res 29:1777–1782

    PubMed  CAS  Google Scholar 

  3. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765–781

    Article  PubMed  CAS  Google Scholar 

  4. Ovsiannikov D, Selinski S, Lehmann ML et al (2012) Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry. J Toxicol Environ Health A 75:557–565

    Article  PubMed  CAS  Google Scholar 

  5. Gong M, Dong W, An R (2012) Glutathione S-transferase T1 Polymorphism Contributes to Bladder Cancer Risk: a Meta-Analysis Involving 50 Studies. DNA Cell Biol 31:1187–1197

    Article  PubMed  CAS  Google Scholar 

  6. Zhang R, Xu G, Chen W et al (2011) Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies. Mol Biol Rep 38:2491–2497

    Article  PubMed  CAS  Google Scholar 

  7. Salinas-Sanchez AS, Sanchez–Sanchez F, Donate-Moreno MJ et al (2011) Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer. BJU Int 107:1825–1832

    Article  PubMed  Google Scholar 

  8. Moore LE, Baris DR, Figueroa JD et al (2011) GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 32:182–189

    Article  PubMed  CAS  Google Scholar 

  9. Jiang Z, Li C, Wang X (2011) Glutathione S-transferase M1 polymorphism and bladder cancer risk: a meta-analysis involving 33 studies. Exp Biol Med 236:723–728

    Article  CAS  Google Scholar 

  10. Cantor KP, Villanueva CM, Silverman DT et al (2010) Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environ Health Perspect 118:1545–1550

    Article  PubMed  CAS  Google Scholar 

  11. Simic T, Savic-Radojevic A, Pljesa-Ercegovac M et al (2009) Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol 6:281–289

    Article  PubMed  CAS  Google Scholar 

  12. Chen B, Cao L, Zhou Y et al (2010) Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiologic studies. Dig Dis Sci 55:1831–1838

    Article  PubMed  CAS  Google Scholar 

  13. Chen B, Zhou Y, Yang P et al (2010) Glutathione S-transferase M1 gene polymorphism and gastric cancer risk: an updated analysis. Arch Med Res 41:558–566

    Article  PubMed  CAS  Google Scholar 

  14. Zhou Y, Li N, Zhuang W et al (2009) Glutathione S-transferase P1 gene polymorphism associated with gastric cancer among Caucasians. Eur J cancer 45:1438–1442

    Article  PubMed  CAS  Google Scholar 

  15. Lo HW, Ali-Osman F (2007) Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol 7:367–374

    Article  PubMed  CAS  Google Scholar 

  16. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    Article  PubMed  CAS  Google Scholar 

  17. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

    Article  PubMed  CAS  Google Scholar 

  18. Harries LW, Stubbins MJ, Forman D et al (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641–644

    Article  PubMed  CAS  Google Scholar 

  19. Peluso M, Airoldi L, Magagnotti C et al (2000) White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer. Carcinogenesis 21:183–187

    Article  PubMed  CAS  Google Scholar 

  20. Steinhoff C, Franke KH, Golka K et al (2000) Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 74:521–526

    Article  PubMed  CAS  Google Scholar 

  21. Toruner GA, Akyerli C, Ucar A et al (2001) Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 75:459–464

    Article  PubMed  CAS  Google Scholar 

  22. Ma QW, Lin GF, Chen JG et al (2002) Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer. Biomed Environ Sci 15:253–260

    PubMed  Google Scholar 

  23. Hung RJ, Boffetta P, Brennan P et al (2004) GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 110:598–604

    Article  PubMed  CAS  Google Scholar 

  24. Broberg K, Bjork J, Paulsson K et al (2005) Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 26:1263–1271

    Article  PubMed  CAS  Google Scholar 

  25. Cao W, Cai L, Rao JY et al (2005) Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 104:2400–2408

    Article  PubMed  CAS  Google Scholar 

  26. Garcia-Closas M, Malats N, Silverman D et al (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366:649–659

    Article  PubMed  CAS  Google Scholar 

  27. Saad AA, O’Connor PJ, Mostafa MH et al (2005) Glutathione S-transferase M1, T1 and P1 polymorphisms and bladder cancer risk in Egyptians. Int J Biol Markers 20:69–72

    PubMed  CAS  Google Scholar 

  28. Srivastava DS, Mishra DK, Mandhani A et al (2005) Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 48:339–344

    Article  PubMed  CAS  Google Scholar 

  29. Xing DL (2006) Association study of polymorphisms in the human drug metabolism enzyme gene and bladder cancer risk. Zhengzhou Daxue 12:1–61

    Google Scholar 

  30. Kopps S, Angeli-Greaves M, Blaszkewicz M et al (2008) Glutathione S-transferase P1 ILE105Val polymorphism in occupationally exposed bladder cancer cases. J Toxicol Environ Health A 71:898–901

    Article  PubMed  CAS  Google Scholar 

  31. Yuan JM, Chan KK, Coetzee GA et al (2008) Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis 29:1386–1393

    Article  PubMed  CAS  Google Scholar 

  32. Altayli E, Gunes S, Yilmaz AF et al (2009) CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol 41:259–266

    Article  PubMed  CAS  Google Scholar 

  33. Fontana L, Delort L, Joumard L et al (2009) Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort. Anticancer Res 29:1631–1635

    PubMed  CAS  Google Scholar 

  34. Grando JP, Kuasne H, Losi-Guembarovski R et al (2009) Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer. Clin Exp Med 9:21–28

    Article  PubMed  CAS  Google Scholar 

  35. Zhang R, Xu G, Chen W et al (2011) Genetic polymorphisms of glutathione S-transferase P1 and bladder cancer susceptibility in a Chinese population. Gene Test Mol Biomarkers 15:85–88

    Article  CAS  Google Scholar 

  36. Lesseur C, Gilbert-Diamond D, Andrew AS et al (2012) A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire. Toxicol Lett 210:100–106

    Article  PubMed  CAS  Google Scholar 

  37. Safarinejad MR, Safarinejad S, Shafiei N (2011) Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Urol oncol. doi:10.1016/j.urolonc.2011.1011.1027

  38. Goerlitz D, El Daly M, Abdel-Hamid M et al (2011) GSTM1, GSTT1 null variants, and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20:1552–1554

    Article  CAS  Google Scholar 

  39. Kellen E, Hemelt M, Broberg K et al (2007) Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 165:1221–1230

    Article  PubMed  Google Scholar 

  40. Katoh T, Kaneko S, Takasawa S et al (1999) Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 9:165–169

    Article  PubMed  CAS  Google Scholar 

  41. Ma Q, Lin G, Qin Y et al (2003) GSTP1 A1578G (Ile105Val) polymorphism in benzidine-exposed workers: an association with cytological grading of exfoliated urothelial cells. Pharmacogenetics 13:409–415

    Article  PubMed  CAS  Google Scholar 

  42. Mittal RD, Srivastava DSAM et al (2005) Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India. Asian Pac J Cancer Prev: APJCP 6:6–9

    PubMed  Google Scholar 

  43. Gago-Dominguez M, Bell DA, Watson MA et al (2003) Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis 24:483–489

    Article  PubMed  CAS  Google Scholar 

  44. Castelao JE, Yuan JM, Gago-Dominguez M et al (2004) Carotenoids/vitamin C and smoking-related bladder cancer. Int J Cancer 110:417–423

    Article  PubMed  CAS  Google Scholar 

  45. Chen B, Zhou Y, Yang P et al (2011) CDH1 −160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer. Cytokine 55:266–273

    Article  PubMed  CAS  Google Scholar 

  46. Zeng FF, Liu SY, Wei W et al (2010) Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis. Clin Exp Med 10:59–68

    Article  PubMed  CAS  Google Scholar 

  47. Reszka E, Jablonowski Z, Wieczorek E et al (2011) GSTP1 mRNA expression in human circulating blood leukocytes is associated with GSTP1 genetic polymorphism. Clin Biochem 44:1153–1155

    Article  PubMed  CAS  Google Scholar 

  48. Pljesa-Ercegovac M, Savic-Radojevic A, Dragicevic D et al (2011) Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways. Urol Oncol 29:70–77

    Article  PubMed  CAS  Google Scholar 

  49. Chen B, Zhou Y, Yang P et al (2011) ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis. J Cancer Res Clin Oncol 137:939–946

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

We declare that no conflict of interest exists for any of the authors.

Author information

Authors and Affiliations

  1. Department of Urology, West China Hospital, Sichuan University, 37 Guo Xue Road, Chengdu, 610041, China

    Ke Wu, Xianding Wang, Zhiyuan Xie, Zhihong Liu & Yiping Lu

Authors
  1. Ke Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xianding Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhiyuan Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhihong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yiping Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yiping Lu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, K., Wang, X., Xie, Z. et al. Glutathione S-transferase P1 gene polymorphism and bladder cancer susceptibility: an updated analysis. Mol Biol Rep 40, 687–695 (2013). https://doi.org/10.1007/s11033-012-2109-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-2109-7

Keywords

Search

Navigation